000 | 01041 a2200277 4500 | ||
---|---|---|---|
005 | 20250513233258.0 | ||
264 | 0 | _c20010405 | |
008 | 200104s 0 0 eng d | ||
022 | _a1465-6566 | ||
024 | 7 |
_a10.1517/14656566.1.1.3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcKaig, B C | |
245 | 0 | 0 |
_aCurrent pharmacotherapy for inflammatory bowel disease. _h[electronic resource] |
260 |
_bExpert opinion on pharmacotherapy _cNov 1999 |
||
300 |
_a3-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
700 | 1 | _aStack, W A | |
773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 1 _gno. 1 _gp. 3-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.1.1.3 _zAvailable from publisher's website |
999 |
_c11186394 _d11186394 |